Clinical Trial: Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional

Official Title: A Randomized, Double-Masked, Parallel-Group, Comparative Study to Evaluate the Clinical Efficacy and Safety of ISV-305 (Dexamethasone in DuraSite®) Compared to Vehicle in the Treatment of Subject

Brief Summary: The purpose of this study is to evaluate the clinical efficacy and safety of ISV-305 (Dexamethasone in DuraSite®) compared to Vehicle in the treatment of subjects with Blepharitis.

Detailed Summary:
Sponsor: InSite Vision

Current Primary Outcome: Clinical Resolution [ Time Frame: Day 15 ]

The primary efficacy endpoint for the comparison of ISV-305 and Vehicle is complete clinical resolution of signs and symptoms at Day 15.


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: InSite Vision

Dates:
Date Received: February 28, 2012
Date Started: July 2017
Date Completion: September 2018
Last Updated: April 11, 2017
Last Verified: April 2017